U.S. top court declines to hear patent case on glaucoma drug
March 31, 2014 at 09:47 AM EDT
WASHINGTON, March 31 (Reuters) - The U.S. Supreme Court on Monday left intact an appeals court ruling that endorsed patent protections for Combigan, Allergan Inc's glaucoma drug.
